These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2997380)

  • 1. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.
    Lemon SM; Binn LN
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2501-5. PubMed ID: 2997380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl.
    Lemon SM; Jansen RW; Newbold JE
    J Virol; 1985 Apr; 54(1):78-85. PubMed ID: 2983123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of incomplete hepatitis A virus particles.
    Ruchti F; Siegl G; Weitz M
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2159-66. PubMed ID: 1654375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a hepatitis A virus candidate vaccine strain.
    Heinricy U; Stierhof YD; Pfisterer M; Flehmig B
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2487-93. PubMed ID: 2821186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus.
    Nasser AM; Metcalf TG
    Appl Environ Microbiol; 1987 Dec; 53(12):2967-71. PubMed ID: 2829721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.
    Beales LP; Wood DJ; Minor PD; Saldanha JA
    J Virol Methods; 1996 May; 59(1-2):147-54. PubMed ID: 8793842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus.
    Cromeans T; Sobsey MD; Fields HA
    J Med Virol; 1987 May; 22(1):45-56. PubMed ID: 3035079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antigenic properties of hepatitis A virus particles possessing different physicochemical characteristics].
    Kusov IuIu; Nastashenko TA; Kazachkov IuA; Donets MA; Grishina GK; Berkova NP; Balaian MS
    Vopr Virusol; 1991; 36(3):203-6. PubMed ID: 1654006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175.
    Anderson DA
    J Med Virol; 1987 May; 22(1):35-44. PubMed ID: 3035078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.
    Rosen E; Stapleton JT; McLinden J
    Vaccine; 1993; 11(7):706-12. PubMed ID: 8393604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Properties of hepatitis A virus particles produced during infection in vitro].
    Kusov IuIu; Kazachkov IuA; Nastashenko TA; Grabko VI; Zavodova TI
    Mol Gen Mikrobiol Virusol; 1987 Mar; (3):14-23. PubMed ID: 3033482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of the accumulation of virus particles with different physico-chemical properties in FRhK-4 cells infected with hepatitis A virus].
    Kusov IuIu; Nastashenko TA; Kazachkov IuA; Panina LI
    Mol Gen Mikrobiol Virusol; 1987 Jan; (1):26-32. PubMed ID: 3031492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis A virus subviral particles: purification, accumulation, and relative infectivity of virions, provirions and procapsids.
    Bishop NE; Anderson DA
    Arch Virol; 1997; 142(11):2147-60. PubMed ID: 9672583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic excretion of hepatitis A virus in experimentally infected chimpanzees: biophysical characterization of the associated HAV particles.
    Bradley DW; Gravelle CR; Cook EH; Fields RM; Maynard JE
    J Med Virol; 1977; 1(2):133-8. PubMed ID: 205631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles.
    Winokur PL; McLinden JH; Stapleton JT
    J Virol; 1991 Sep; 65(9):5029-36. PubMed ID: 1651421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of noninfectious hepatitis A virus hemagglutinin for detecting hemagglutination inhibition antibodies.
    Dubois DR; Binn LN; Summers PL; Timchak RL; Barvir DA; Marchwicki RH; Eckels KH
    J Virol Methods; 1990 Jun; 28(3):299-304. PubMed ID: 2166750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physicochemical properties of infectious hepatitis A virions.
    Siegl G; Frösner GG; Gauss-Müller V; Tratschin JD; Deinhardt F
    J Gen Virol; 1981 Dec; 57(Pt 2):331-41. PubMed ID: 6172556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.